Putative association between UBE2E2 polymorphisms and the risk of gestational diabetes mellitus

References

• Metzger BE. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1991;40:197–201
   PubMed Web of Science ®Google Scholar
• Amankwah K, Prentice R, Fleury F. The incidence of gestational diabetes. Obstet Gynecol 1977;49:497–8
   PubMedGoogle Scholar
• Cho YM, Kim TH, Lim S, et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 2009;52:253–61
   PubMed Web of Science ®Google Scholar
• Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA 2001;286:2516–8
   PubMed Web of Science ®Google Scholar
• Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485–91
   PubMed Web of Science ®Google Scholar
• Evans JC, Frayling TM, Cassell PG, et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001;69:544–52
   PubMedGoogle Scholar
• Salonen JT, Uimari P, Aalto JM, et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 2007;81:338–45
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 2010;42:864–8
   PubMed Web of Science ®Google Scholar
• Ito K, Kato S, Matsuda Y, et al. cDNA cloning, characterization, and chromosome mapping of UBE2E3 (alias UbcH9), encoding an N-terminally extended human ubiquitin-conjugating enzyme. Cytogenet Cell Genet 1999;84:99–104
   PubMedGoogle Scholar
• Hartley T, Brumell J, Volchuk A. Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic beta-cells. Am J Physiol Endocrinol Metab 2009;296:E1–10
   PubMed Web of Science ®Google Scholar
• Kitiphongspattana K, Mathews CE, Leiter EH, Gaskins HR. Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic beta-cells. J Biol Chem 2005;280:15727–34
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Minami K, Nagashima K, Seino S. Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion. J Biol Chem 2006;281:13015–20
   PubMed Web of Science ®Google Scholar
• Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care 2007;30 Suppl 2:S105–11
   Google Scholar
• Kwak SH, Kim SH, Cho YM, et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 2012;61:531–41
   PubMed Web of Science ®Google Scholar
• Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009;41:89–94
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–73
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9
   PubMed Web of Science ®Google Scholar
• Krzyzanowska K, Zemany L, Krugluger W, et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 2008;51:1115–22
   PubMed Web of Science ®Google Scholar
• Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143–9
   PubMedGoogle Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263–5
   PubMed Web of Science ®Google Scholar
• Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978–89
   PubMed Web of Science ®Google Scholar
• Kim JY, Cheong HS, Park BL, et al. Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus. BMC Med Genet 2011;12:82
   PubMed Web of Science ®Google Scholar
• Shin HD, Park BL, Shin HJ, et al. Association of KCNQ1 polymorphisms with the gestational diabetes mellitus in Korean women. J Clin Endocrinol Metab 2010;95:445–9
   PubMed Web of Science ®Google Scholar
• Marfella R, D'Amico M, Esposito K, et al. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes 2006;55:622–32
   PubMedGoogle Scholar
• Chang TL, Chang CJ, Lee WY, et al. The roles of ubiquitin and 26S proteasome in human obesity. Metabolism 2009;58:1643–8
   PubMedGoogle Scholar
• Balasubramanyam M, Sampathkumar R, Mohan V. Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation? Mol Cell Biochem 2005;275:117–25
   PubMed Web of Science ®Google Scholar
• Pagani F, Baralle FE. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 2004;5:389–96
   PubMed Web of Science ®Google Scholar
• Brinster RL, Allen JM, Behringer RR, et al. Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci U S A 1988;85:836–40
   PubMed Web of Science ®Google Scholar
• Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009;41:77–81
   PubMed Web of Science ®Google Scholar
• Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092–7
   PubMed Web of Science ®Google Scholar
• Rome S, Meugnier E, Vidal H. The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling. Curr Opin Clin Nutr Metab Care 2004;7:249–54
   PubMed Web of Science ®Google Scholar